S&P 500 Futures
(0.17%) 5 140.25 points
Dow Jones Futures
(0.10%) 38 478 points
Nasdaq Futures
(0.28%) 17 896 points
Oil
(-0.06%) $83.80
Gas
(1.09%) $1.944
Gold
(0.24%) $2 352.80
Silver
(0.51%) $27.68
Platinum
(2.02%) $940.70
USD/EUR
(-0.20%) $0.933
USD/NOK
(-0.27%) $10.99
USD/GBP
(-0.32%) $0.798
USD/RUB
(1.29%) $93.06

Realaus laiko atnaujinimai IDEXX Laboratories Inc [IDXX]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Diagnostics & Research
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-04-30)

Expected move: +/- 6.98%

BUY
58.62%
return -8.23%
SELL
35.71%
return 6.08%
Atnaujinta26 bal. 2024 @ 23:00

2.06% $ 499.30

PARDAVIMAS 5391 min ago

@ $487.30

Išleistas: 25 bal. 2024 @ 20:24


Grąža: 2.46%


Ankstesnis signalas: bal. 25 - 16:31


Ankstesnis signalas: Pirkimas


Grąža: -0.66 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by 0.23% compare to its pairs and should correct downwards.
Profile picture for IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide...

Stats
Šios dienos apimtis 529 831
Vidutinė apimtis 422 783
Rinkos kapitalizacija 41.49B
EPS $0 ( 2024-02-05 )
Kita pelno data ( $0 ) 2024-04-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 49.73
ATR14 $15.92 (3.19%)
Insider Trading
Date Person Action Amount type
2024-03-06 Polewaczyk James F Buy 4 640 Common Stock
2024-03-06 Polewaczyk James F Sell 4 134 Common Stock
2024-03-06 Polewaczyk James F Buy 2 226 Common Stock
2024-03-06 Polewaczyk James F Buy 483 Common Stock
2024-03-06 Polewaczyk James F Buy 755 Common Stock
INSIDER POWER
37.68
Last 100 transactions
Buy: 74 111 | Sell: 33 078
Koreliacija (AI algo v.1.1b): Overvalued: -0.23% $497.95 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.87 (strong)
Trumpas: -0.22 (neutral)
Signal:(49) Neutral

IDEXX Laboratories Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
RYAAY0.927
IPKW0.927
HOLX0.926
HOFT0.923
OCAX0.921
STRA0.919
LBTYK0.918
PRIM0.917
LBTYA0.915
FRSG0.913
10 Labiausiai neigiamai susiję koreliacijos
SVAC-0.919
RMRM-0.909
AMGN-0.908
TLGT-0.906
GHVI-0.897
AXGN-0.896
AHPI-0.893
STAB-0.891
RTPY-0.89
SMIT-0.882

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

IDEXX Laboratories Inc Koreliacija - Valiuta/Žaliavos

The country flag -0.24
( neutral )
The country flag 0.52
( weak )
The country flag 0.65
( weak )
The country flag 0.02
( neutral )
The country flag -0.05
( neutral )
The country flag 0.26
( neutral )

IDEXX Laboratories Inc Finansinės ataskaitos

Annual 2023
Pajamos: $3.66B
Bruto pelnas: $2.19B (59.82 %)
EPS: $10.17
FY 2023
Pajamos: $3.66B
Bruto pelnas: $2.19B (59.82 %)
EPS: $10.17
FY 2022
Pajamos: $3.37B
Bruto pelnas: $2.00B (59.52 %)
EPS: $8.12
FY 2021
Pajamos: $3.22B
Bruto pelnas: $1.89B (58.76 %)
EPS: $8.74

Financial Reports:

Symbol Period Year Title
IDXX Q4 2023 IDEXX Laboratories, Inc. - Q4 2023 Financial Report

IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.